The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review
Abstract Background For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversion of initially unresectable CRLM. First conducted...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-017-1212-6 |
id |
doaj-6c2623029ec24da7a08827849eba34fb |
---|---|
record_format |
Article |
spelling |
doaj-6c2623029ec24da7a08827849eba34fb2020-11-25T02:32:02ZengBMCWorld Journal of Surgical Oncology1477-78192017-08-011511510.1186/s12957-017-1212-6The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature reviewNan Xiao0Kailin Yu1Shaojun Yu2Jianjun Wu3Jian Wang4Siyang Shan5Shuchun Zheng6Liuhong Wang7Jianwei Wang8Shuyou Peng9Department of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Radiology and Intervention, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Radiology and Intervention, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of MedicineDepartment of General Surgery, Second Affiliated Hospital of Zhejiang University School of MedicineAbstract Background For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversion of initially unresectable CRLM. First conducted in 2012, associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) allows rapid liver growth. As a means to induce hypertrophy, portal vein embolization (PVE) has been widely applied before extending hepatectomy. Recently, Peng et al. present a new approach of terminal branches portal vein embolization (TBPVE), offering an efficient way to amplify FLR and making chances for surgery in 2 weeks. Case presentation We reported a 61-year-old woman with synchronous hepatic metastasized carcinoma of the colon sigmoideum underwent TBPVE after 6 cycles of neoadjuvant therapy in order to perform a planned right trisectionectomy. Rapid liver remnant hypertrophy and remarkable tumor shrinkage were achieved, and laparoscopic sigmoidectomy and right trisectionectomy were successfully performed. The postsurgical course was uneventful and 7 months of recurrence-free survival have been witnessed. Conclusions The dual tactics of tumor shrinkage and planned rapid liver remnant hypertrophy will make concerted efforts to further increase the clinical candidacy for curative resection, which are valuable for further investigation.http://link.springer.com/article/10.1186/s12957-017-1212-6Tumor shrinkageLiver remnant hypertrophyUnresectable colorectal liver metastasisPreoperative chemotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nan Xiao Kailin Yu Shaojun Yu Jianjun Wu Jian Wang Siyang Shan Shuchun Zheng Liuhong Wang Jianwei Wang Shuyou Peng |
spellingShingle |
Nan Xiao Kailin Yu Shaojun Yu Jianjun Wu Jian Wang Siyang Shan Shuchun Zheng Liuhong Wang Jianwei Wang Shuyou Peng The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review World Journal of Surgical Oncology Tumor shrinkage Liver remnant hypertrophy Unresectable colorectal liver metastasis Preoperative chemotherapy |
author_facet |
Nan Xiao Kailin Yu Shaojun Yu Jianjun Wu Jian Wang Siyang Shan Shuchun Zheng Liuhong Wang Jianwei Wang Shuyou Peng |
author_sort |
Nan Xiao |
title |
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review |
title_short |
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review |
title_full |
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review |
title_fullStr |
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review |
title_full_unstemmed |
The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review |
title_sort |
paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review |
publisher |
BMC |
series |
World Journal of Surgical Oncology |
issn |
1477-7819 |
publishDate |
2017-08-01 |
description |
Abstract Background For colorectal liver metastasis (CRLM) patients, hepatic resection is currently the sole cure offering the chance of long-term survival. Tumor shrinkage and planned liver remnant hypertrophy are the two key strategies for conversion of initially unresectable CRLM. First conducted in 2012, associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) allows rapid liver growth. As a means to induce hypertrophy, portal vein embolization (PVE) has been widely applied before extending hepatectomy. Recently, Peng et al. present a new approach of terminal branches portal vein embolization (TBPVE), offering an efficient way to amplify FLR and making chances for surgery in 2 weeks. Case presentation We reported a 61-year-old woman with synchronous hepatic metastasized carcinoma of the colon sigmoideum underwent TBPVE after 6 cycles of neoadjuvant therapy in order to perform a planned right trisectionectomy. Rapid liver remnant hypertrophy and remarkable tumor shrinkage were achieved, and laparoscopic sigmoidectomy and right trisectionectomy were successfully performed. The postsurgical course was uneventful and 7 months of recurrence-free survival have been witnessed. Conclusions The dual tactics of tumor shrinkage and planned rapid liver remnant hypertrophy will make concerted efforts to further increase the clinical candidacy for curative resection, which are valuable for further investigation. |
topic |
Tumor shrinkage Liver remnant hypertrophy Unresectable colorectal liver metastasis Preoperative chemotherapy |
url |
http://link.springer.com/article/10.1186/s12957-017-1212-6 |
work_keys_str_mv |
AT nanxiao theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT kailinyu theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT shaojunyu theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT jianjunwu theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT jianwang theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT siyangshan theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT shuchunzheng theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT liuhongwang theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT jianweiwang theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT shuyoupeng theparadigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT nanxiao paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT kailinyu paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT shaojunyu paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT jianjunwu paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT jianwang paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT siyangshan paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT shuchunzheng paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT liuhongwang paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT jianweiwang paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview AT shuyoupeng paradigmoftumorshrinkageandrapidliverremnanthypertrophyforconversionofinitiallyunresectablecolorectallivermetastasisacasereportandliteraturereview |
_version_ |
1724821986426748928 |